Cargando…
Biomarkers to Be Used for Decision of Treatment of Hypogonadal Men with or without Insulin Resistance
Male hypogonadism is a result of low testosterone levels, but patients could be insulin-sensitive (IS) or insulin-resistant (IR), showing different impaired metabolic pathways. Thus, testosterone coadministration, which is commonly used to reestablish testosterone levels in hypogonadism, must take i...
Autor principal: | Zolla, Lello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303871/ https://www.ncbi.nlm.nih.gov/pubmed/37367840 http://dx.doi.org/10.3390/metabo13060681 |
Ejemplares similares
-
Metabolic patterns in insulin-resistant male hypogonadism
por: Gevi, Federica, et al.
Publicado: (2018) -
Plasma Metabonomics in Insulin-Resistant Hypogonadic Patients Induced by Testosterone Treatment
por: Zolla, Lello, et al.
Publicado: (2022) -
Metabolic patterns in insulin-sensitive male hypogonadism
por: Fanelli, Giuseppina, et al.
Publicado: (2018) -
Plasma Metabolomics Profile of “Insulin Sensitive” Male Hypogonadism after Testosterone Replacement Therapy
por: Zolla, Lello, et al.
Publicado: (2022) -
Testosterone replacement therapy in insulin‐sensitive hypogonadal men restores phosphatidylcholine levels by regulation of arachidonic acid metabolism
por: Fanelli, Giuseppina, et al.
Publicado: (2020)